Insiders · Profile

Teleman Dan Benjamin

Chief Executive Officer at Nasus Pharma. Filing since 31 Mar 2026. CIK 0002122500

Company

Date

Role

Action

Amount

Of holding

17 Jun 2026

Chief Executive Officer

Bought

6,550

$20.31K

4.2%

22 Apr 2026

Chief Executive Officer

Bought

2,900

$10.90K

1.9%

31 Mar 2026

Chief Executive Officer

Bought

15,000

$30.60K

240%

3 decisions on file.